TY - JOUR
T1 - ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use
AU - Bhatt, Deepak L.
AU - Scheiman, James
AU - Abraham, Neena S.
AU - Antman, Elliott M.
AU - Chan, Francis K.L.
AU - Furberg, Curt D.
AU - Johnson, David A.
AU - Mahaffey, Kenneth W.
AU - Quigley, Eamonn M.
AU - Harrington, Robert A.
AU - Bates, Eric R.
AU - Bridges, Charles R.
AU - Eisenberg, Mark J.
AU - Ferrari, Victor A.
AU - Hlatky, Mark A.
AU - Kaul, Sanjay
AU - Lindner, Jonathan R.
AU - Moliterno, David J.
AU - Mukherjee, Debabrata
AU - Schofield, Richard S.
AU - Rosenson, Robert S.
AU - Stein, James H.
AU - Weitz, Howard H.
AU - Wesley, Deborah J.
PY - 2008/11
Y1 - 2008/11
N2 - In appropriate patients oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H. pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.
AB - In appropriate patients oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications. Of the major bleeding that occurs, the largest proportion is due to GI hemorrhage. Concomitant use of NSAIDs further raises the risk of GI bleeding. Gastroprotection strategies consist of use of PPIs in patients at high risk of GI bleeding and eradication of H. pylori in patients with a history of ulcers. Communication between cardiologists, gastroenterologists, and primary care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding.
UR - http://www.scopus.com/inward/record.url?scp=55549124570&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55549124570&partnerID=8YFLogxK
U2 - 10.1111/j.1572-0241.2008.02216.x
DO - 10.1111/j.1572-0241.2008.02216.x
M3 - Review article
C2 - 18853965
AN - SCOPUS:55549124570
SN - 0002-9270
VL - 103
SP - 2890
EP - 2907
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 11
ER -